Northern Trust Corp Organogenesis Holdings Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Northern Trust Corp holds 616,089 shares of ORGO stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

616,089

Previous 598,893 2.87%

Holding current value

$3.09 Million

Previous $1.71 Million 15.13%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.77 - $4.43 $47,632 - $76,178	17,196 Added 2.87%	616,089 $1.97 Million
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $23,953 - $32,069	9,898 Added 1.68%	598,893 $1.71 Million
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $62,914 - $83,609	-27,594 Reduced 4.48%	588,995 $1.65 Million
Q1 2024 May 14, 2024	SELL	$2.61 - $4.49 $24,319 - $41,837	-9,318 Reduced 1.49%	616,589 $1.75 Million
Q4 2023 Feb 13, 2024	BUY	$1.97 - $4.21 $6,443 - $13,770	3,271 Added 0.53%	625,907 $2.56 Million
Q3 2023 Nov 13, 2023	BUY	$2.34 - $4.43 $50,370 - $95,360	21,526 Added 3.58%	622,636 $1.98 Million
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $182,764 - $413,625	-96,192 Reduced 13.79%	601,110 $2 Million
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $81,763 - $126,754	-43,261 Reduced 5.84%	697,302 $1.49 Million
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $131,891 - $182,414	53,182 Added 7.74%	740,563 $1.99 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $41,633 - $85,255	13,259 Added 1.97%	687,381 $2.23 Million
Q2 2022 Aug 12, 2022	BUY	$4.74 - $8.15 $3,630 - $6,242	766 Added 0.11%	674,122 $3.29 Million
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $1.3 Million - $1.93 Million	201,487 Added 42.7%	673,356 $5.13 Million
Q4 2021 Feb 08, 2022	BUY	$9.02 - $13.5 $23,641 - $35,383	2,621 Added 0.56%	471,869 $4.36 Million
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $182,178 - $228,287	-13,288 Reduced 2.75%	469,248 $6.68 Million
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $2.26 Million - $3.52 Million	151,586 Added 45.8%	482,536 $8.02 Million
Q1 2021 May 12, 2021	SELL	$7.33 - $21.06 $12,065 - $34,664	-1,646 Reduced 0.49%	330,950 $6.03 Million
Q4 2020 Feb 11, 2021	BUY	$3.63 - $7.53 $229,793 - $476,679	63,304 Added 23.51%	332,596 $2.5 Million
Q3 2020 Nov 16, 2020	SELL	$3.29 - $4.58 $32,413 - $45,122	-9,852 Reduced 3.53%	269,292 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$2.86 - $4.61 $210,304 - $338,987	73,533 Added 35.76%	279,144 $1.07 Million
Q1 2020 May 14, 2020	BUY	$2.92 - $5.31 $152,567 - $277,442	52,249 Added 34.07%	205,611 $664,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $175,018 - $302,000	37,238 Added 32.07%	153,362 $737,000
Q3 2019 Nov 13, 2019	BUY	$3.57 - $8.09 $267,957 - $607,219	75,058 Added 182.77%	116,124 $763,000
Q2 2019 Aug 13, 2019	BUY	$6.58 - $8.69 $154,893 - $204,562	23,540 Added 134.31%	41,066 $312,000
Q1 2019 May 13, 2019	BUY	$7.05 - $150.0 $123,558 - $2.63 Million	17,526 New	17,526 $131,000

Others Institutions Holding ORGO

# of Institutions

124

Shares Held

62M

Call Options Held

4.3K

Put Options Held

3.9K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $656M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Organogenesis Holdings Inc. Transaction History